Sequence-Selective Translation Inhibition as a Novel, Proximity-Based Small Molecule Therapeutic Modality
- Drug-like small-molecule, sequence-selective interdiction of disease associated protein synthesis
- Addressing highly validated yet historically undruggable targets in oncology and neurodegeneration
- Strong reliance on machine learning fueled by biophysical characterization, cryo-EM, ribosome profiling and genomics